We have been listed on the Warsaw Stock Exchange since 2013, having debuted as the first local company in the biotechnology sector.

Analysts publishing reports on Mabion S.A.

Analyst Institution Date
Dawid Górzyński BM PKOBP 06.05.2021
Tomasz Krukowski BM Santander 03.12.2021
Marcin Palenik Millennium DM 14.12.2021
Beata Szparaga-Waśniewska Ipopema Securities 14.12.2021

Links to pages

National Depository for Securities


Warsaw Stock Exchange


Financial Supervision Authority